Objectives To establish a practical method to improve compliance of the academic guidelines in dialysis units in Beijing. Methods Quantitative scoring strategy was built up based on the practicable clinical parameters and the guidelines from other countries. The rate of compliance with the guidelines and the rate of guideline performance during the period from 2014 to 2020 were calculated using the data from the database in Beijing Blood Purification Quality Control and Improvement Center. The dialysis units were then ranked according to the total scores of compliance rate and guideline performance rate. Results Eight clinical parameters were incorporated in the quantitative scoring strategy: hemoglobin, serum albumin, ferritin, calcium, phosphorus, iPTH, URR, and Kt/V. After implementation of the strategy for 5 years, the compliance and performance rates for hemoglobin (from 58.7% to 79.7%, χ2=18.339, P=0.005), serum albumin (from 82.2% to 85.6%, χ2=0.253, P=0.615), ferritin (from 47.5% to 63.4%, χ2=8.935, P=0.003), calcium ( χ2=5.113, P=0.024), phosphorus (from 41.7% to 47.6%), and iPTH (from 28.2% to 35.3%, χ2=2.037, P=0.153) increased steadily, but URR and Kt/V were slightly reduced in spite of their appropriate guideline performance. Conclusions The quantitative scoring strategy is a simple and practicable tool for administration and management of blood purification quality control and improvement.
ZHANG Yue
,
DIAO Zong-Li
,
GUO Wang
,
WEI Tao
,
LIU Wen-Hu
. Establishment and clinical practice of quantitative scoring strategy for hemodialysis quality control and improvement management in Beijing[J]. Chinese Journal of Blood Purification, 2023
, 22(1)
: 73
-78
.
DOI: 10.3969/j.issn.1671-4091.2023.01.017
[1]Wang J, Lv J, He K, et al.Longitudinal Follow-Up and Outcomes for Chinese Patients with Stage 1-4 Chronic Kidney Disease. Kidney Dis (Basel), 2022, 8: 72-81.[J].Kidney Dis (Basel), 2022, 8:72-81
[2]Yang C, Wang H, Zhao X, et al.CKD in China: Evolving Spectrum and Public Health Implications. Am J Kidney Dis, 2020, 76: 258-264.[J].Am J Kidney Dis, 2020, 76:258-264
[3]Yoshikoshi S, Yamamoto S, Suzuki Y, et al.Associations between dynapenia, cardiovascular hospitalizations, and all-cause mortality among patients on haemodialysis. J Cachexia Sarcopenia Muscle, 2022 .[J].J Cachexia Sarcopenia Muscle, 2022, :-
[4]Wilkinson TJ, Miksza J, Zaccardi F, et al.Associations between frailty trajectories and cardiovascular, renal, and mortality outcomes in chronic kidney disease. J Cachexia Sarcopenia Muscle, 2022 .[J].J Cachexia Sarcopenia Muscle, 2022, :-
[5]Du L, Sun H, Lu J, et al.Effects of dialysis modality on mortality in patients with end-stage renal disease: A cohort study. Semin Dial, 2022 .[J].Semin Dial, 2022, :-
[6]刁宗礼, 郭王, 黄红东, 等.2016~2020 年北京市血液透析患者流行病学调查. 医学研究杂志, 2022, 51: 114-117.[J].医学研究杂志, 2022, 51:114-117
[7]Itaya T, Shimizu S, Hara T, et al.Association between facility-level adherence to phosphorus management guidelines and mortality in haemodialysis patients: a prospective cohort study. BMJ Open, 2021, 11: e051002.[J].BMJ Open, 2021, 11:-
[8]Zhang P, Sang S, Huang J, et al.Effect of Calcium-based Phosphate Binders Versus Sevelamer on Mortality of Patients with Hemodialysis: A Meta-analysis. Iran J Kidney Dis, 2022, 16: 215-227.[J].Iran J Kidney Dis, 2022, 16:215-227
[9]Brandenburg V, Ketteler M.Vitamin D and Secondary Hyperparathyroidism in Chronic Kidney Disease: A Critical Appraisal of the Past, Present, and the Future. Nutrients, 2022, 14 .[J].Nutrients,, 2022, 14:-
[10]Xu Y, Evans M, Soro M, et al.Secondary hyperparathyroidism and adverse health outcomes in adults with chronic kidney disease. Clin Kidney J, 2021, 14: 2213-2220.[J].Clin Kidney J, 2021, 14:2213-2220
[11]Diao Z, Qian L, Teng C, et al.Microwave ablation versus parathyroidectomy for severe secondary hyperparathyroidism in patients on hemodialysis: a retrospective multicenter study. Int J Hyperthermia, 2021, 38: 213-219.[J].Int J Hyperthermia, 2021, 38:213-219
